Importance of dose and duration of β-lactam therapy in nasopharyngeal colonization with resistant pneumococci

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue SUPPL. 2, 2002, Pages 39-43

  Canet, Joan Josep ^a   Garau, Javier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CLINICAL STUDY; CONCENTRATION RESPONSE; DISEASE CARRIER; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; DRUG SELECTIVITY; DRUG USE; FREQUENCY ANALYSIS; HUMAN; NASOPHARYNX; NONHUMAN; PENICILLIN RESISTANCE; PRESCRIPTION; PREVALENCE; REVIEW; RHINOPHARYNGITIS; RISK FACTOR; SHORT COURSE THERAPY; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; HUMANS; NASOPHARYNGEAL DISEASES; STREPTOCOCCUS PNEUMONIAE;

EID: 0036986414     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf507     Document Type: Review

References (28)

1. Baquero, F. (1996). Trends in antimicrobial resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, 117-32.
2. Mackowiak, P. A. (1982). The normal microbial flora. New England Journal of Medicine 307, 83-93.
3. Gray, B. M., Converse, G. M. & Dillon, H. C. (1980). Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. Journal of Infectious Diseases 142, 923-33.
4. Ghaffar, F., Friedland, I. R. & McCracken, G. H. (1999). Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatric Infectious Disease Journal 18, 638-46.
5. Kristinsson, K. G. (1999). Modification of prescriber's behavior: the Icelandic approach. Clinical Microbiology and Infection 5, Suppl. 4, S43-7.
6. Garau, J. (2001). Have guidelines had an impact on antimicrobial resistance? Seminars in Respiratory Infection 16, 210-4.
7. Strömberg, A., Friberg, U. & Cars, O. (1987). Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid. European Journal of Clinical Microbiology 6, 525-9.
8. Moreillon, P. & Tomasz, A. (1988). Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment. Journal of Infectious Diseases 157, 1150-7.
9. Negri, M. C., Morosini, M. I., Loza, E. & Baquero, F. (1994). In vitro selective antibiotic concentrations of β-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrobial Agents and Chemotherapy 38, 122-5.
10. Drusano, G. L. & Goldstein, F. W. (1996). Relevance of the Alexander Project: pharmacodynamic considerations. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 141-54.
11. Sifaoui, F., Kitzis, M. D. & Gutmann, L. (1996). In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral β-lactam antibiotics is associated with alterations of PBP2x. Antimicrobial Agents and Chemotherapy 40, 152-6.
12. Guillemot, D., Carbon, C., Balkau, B., Geslin, P., Lecoeur, H., Vauzelle, F. et al. (1998). Low dosage and long treatment duration of β-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. Journal of the American Medical Association 279, 365-70.
13. Schrag, S. J., Peña, C., Fernández, J., Sánchez, J., Gómez, V., Pérez, E. et al. (2001). Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage. Journal of the American Medical Association 286, 49-56.
14. Craig, W. A. (2001). Does the dose matter? Clinical Infectious Diseases 33, Suppl. 3, S233-7.
15. Zhao, X. & Drlica, K. (2001). Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies. Clinical Infectious Diseases 33, Suppl. 3, S147-56.
16. Baquero, F., Negri, C., Morosini, M. I. & Blázquez, J. (1997). The antibiotic selective process: concentration-specific amplification of low-level resistant populations. Ciba Foundation Symposium 207, 93-111.
17. Nasrin, D., Collignon, P. J., Roberts, L., Wilson, E. J., Pilotto, L. S. & Douglas, R. M. (2002). Effect of β-lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. British Medical Journal 324, 28-30.
18. Brook, I. & Gober, A. E. (1996). Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clinical Infectious Diseases 22, 143-5.
19. Syrjänen, R. K., Kilpi, T. M., Kaijalainen, T. H., Herva, E. E. & Takala, A. K. (2001). Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. Journal of Infectious Diseases 184, 451-9.
20. Craig, W. A. (1998). Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26, 1-10.
21. Dancer, S. J. (2001). The problem with cephalosporins. Journal of Antimicrobial Chemotherapy 48, 463-78.
22. Arason, V. A., Kristinsson, K. G., Sigurdsson, J. A., Stefánsdóttir, G., Mölstad, S. & Gudmundsson, S. (1996). Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. British Medical Journal 313, 387-91.
23. Cohen, R., Navel, M., Grunberg, J., Boucherat, M., Geslin, P., Derriennic, M. et al. (1999). One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatric Infectious Disease Journal 18, 403-9.
24. Cohen, R., Bingen, E., Varon, E., De La Rocque, F., Brahimi, N., Levy, C. et al. (1997). Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatric Infectious Disease Journal 16, 555-60.
25. Dagan, R., Leibovitz, E., Greenberg, D., Yagupsky, P., Fliss, D. M. & Leiberman, A. (1998). Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatric Infectious Disease Jouma1 17, 880-5.
26. Dabernat, H., Geslin, P., Megraud, F., Bégué, P., Boulesteix, J., Dubreuil, C. et al. (1998). Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Journal of Antimicrobial Chemotherapy 41, 253-8.
27. Givon-Lavi, N., Dagan, R., Fraser, D., Yagupsky, P. Porat, N. (1999). Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area. Clinical Infectious Diseases 29, 1274-80.
28. Mbelle, N., Huebner, R. E., Wasas A. D., Kimura, A., Chang, I. & Klugman, K.P. (1999). Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. Journal of Infectious Diseases 180, 1171-6.